<DOC>
	<DOCNO>NCT03003065</DOCNO>
	<brief_summary>In study , hope evaluate safety PDT use temoporfin plus endoscopic stent patient inoperable bile duct cancer . In addition preliminary study seek determine treatment reduce tumor volume short term .</brief_summary>
	<brief_title>Safety Tumoricidal Effect Low Dose Foscan PDT Patients With Inoperable Bile Duct Cancers</brief_title>
	<detailed_description>Cholangiocarcinoma tumor associate grave prognosis . The curative treatment surgery liver transplantation . Only 10-20 % patient tumor operate upon . In majority patient , tumor often diagnose late stage . Many patient operate upon owe advanced age comorbid illness . These patient suffer intense pruritus result obstructive jaundice , recurrent biliary sepsis progressive hepatic failure lead death . Quality life patient poor . The median survival patient around 6 month . The palliative treatment stent insert either ERCP percutaneous transhepatic route . Many return recurrent cholangitis necessitate frequent stent change . Photodynamic therapy ( PDT ) combination stenting proven treatment confers survival benefit compare stenting alone . Two randomize control trial show significant survival advantage patient treat PDT addition stenting compare stenting alone . Ortner et al . 1 randomize 39 patient inoperable cholangiocarinoma endoscopic stent without PDT . Median survival give PDT 493 day compare 98 day stent alone . Survival difference wide favor PDT use another randomize control study Zoepf et al 2 ( median survival 630 vs. 210 day ) . In addition , PDT improve quality life cholestasis patient cholangiocarcinoma . In series Germany , survival PDT stenting compare favorably R1 R2 resection . 3 Despite evidence , PDT inoperable cholangiocarcinoma available Hong Kong . Meso-tetrahydroxyphenylchlorin ( mTHPC , Foscan® ) photosensitizer PDT cholangiocarcinoma . In compare agent Photofin Photosan , PDT treatment use temoporfin low dose ( 3 mg per treatment ) associate deep tissue penetration ( 4-6mm ) reduce period photosensitivity . In study , hope evaluate safety PDT use temoporfin plus endoscopic stent patient inoperable bile duct cancer . In addition preliminary study seek determine treatment reduce tumor volume short term .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<mesh_term>Temoporfin</mesh_term>
	<criteria>Patients inoperable cholangiocarcinoma belong Bismuth Corlette classification . Karnofsky index &gt; 30 % Satisfactory relief jaundice ( serum bilirubin &lt; 100µmol/L ) biliary prosthesis insert either ERCP via percutaneous transhepatic route . Absence biliary sepsis Age 1880 Provision write consent No evidence metastatic disease Porphyria Previous insert metallic biliary stent Refusal provide write consent . Moribund disseminate disease comorbidities Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Inoperable cholangiocarcinoma</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Endoscopic retrograde cholangiopancreatography</keyword>
</DOC>